These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3165485)

  • 1. Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia.
    Sokal JE; Gockerman JP; Bigner SH
    Leuk Res; 1988; 12(6):453-8. PubMed ID: 3165485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol.
    Slapak CA; Desforges JF; Fogaren T; Miller KB
    Am J Hematol; 1992 Nov; 41(3):178-83. PubMed ID: 1415192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 6. Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine.
    Robertson MJ; Tantravahi R; Griffin JD; Canellos GP; Cannistra SA
    Am J Hematol; 1993 Jun; 43(2):95-102. PubMed ID: 8342558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose cytosine arabinoside in acute myeloid leukemia: remission is not due to differentiation induction.
    Pinkerton PH; London B; Cowan DH
    Am J Hematol; 1985 Aug; 19(4):415-7. PubMed ID: 3861090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia.
    Sokal JE; Leong SS; Gomez GA
    Cancer; 1987 Jan; 59(1):197-202. PubMed ID: 3466662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia.
    Apperley JF; Rassool F; Parreira A; Geary CG; Harrison C; Stansfield D; Goldman JM
    Am J Hematol; 1986 Jun; 22(2):199-204. PubMed ID: 3518418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapy.
    Smalley RV; Vogel J; Huguley CM; Miller D
    Blood; 1977 Jul; 50(1):107-13. PubMed ID: 266951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
    Petti MC; Tafuri A; Latagliata R; Aloe Spiriti MA; Montefusco E; Mancini M; Meloni G; Petrucci MT; Spadea A; Redi R; Alimena G; Mandelli F
    Ann Hematol; 2003 Aug; 82(8):476-480. PubMed ID: 12835916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia].
    Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F
    Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
    Caballero MD; González M; Cañizo MC; Orfao A; Nieto MJ; San Miguel JF
    Leukemia; 1992 Aug; 6(8):856-8. PubMed ID: 1640739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.
    Griffin JD; Spriggs D; Wisch JS; Kufe DW
    J Clin Oncol; 1985 Jul; 3(7):982-91. PubMed ID: 4020409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of early acute nonlymphatic leukemia with low dose cytosine arabinoside.
    Moloney WC; Rosenthal DS
    Haematol Blood Transfus; 1981; 26():59-62. PubMed ID: 7033074
    [No Abstract]   [Full Text] [Related]  

  • 19. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
    Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases.
    Solal-Celigny P; Desaint B; Herrera A; Chastang C; Amar M; Vroclans M; Brousse N; Mancilla F; Renoux M; Bernard JF
    Blood; 1984 Mar; 63(3):634-8. PubMed ID: 6582939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.